Compound Detail
CHEMBL3287735
GSK2816126 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
CC[C@H](C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(-c3ccc(N4CCNCC4)nc3)cc21
Basic Information
| ChEMBL ID | CHEMBL3287735 |
| Name | GSK2816126 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | FKSFKBQGSFSOSM-QFIPXVFZSA-N |
21
Targets
53
Activities
3
Assay Types
2
PK Parameters
20
Publications
1
Known Names
2
Indications
1
Mechanisms
Molecular Properties
526.7
MW (Da)
4.63
ALogP
6
HBA
3
HBD
95.0
PSA (Ų)
0.33
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Unknown |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Histone-lysine N-methyltransferase EZH2 inhibitor | INHIBITOR | Histone-lysine N-methyltransferase EZH2 | ✓ | ✓ |
Indications
Neoplasms Neoplasms
Activity Summary
IC50 43 meas. best 9.0
Ki 8 meas. best 9.3
Kd 2 meas. best 7.66
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histone-lysine N-methyltransferase EZH2 CHEMBL2189110 | Ki | 9.3 | 9.3 | 0.5 | 8 |
| Histone-lysine N-methyltransferase EZH2 CHEMBL2189110 | IC50 | 9.0 | 8.0964 | 1.0 | 14 |
| A549 CHEMBL392 | IC50 | 8.16 | 6.81 | 6.9 | 3 |
| EZH2/SUZ12/EED complex CHEMBL3137286 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 7.66 | 7.66 | 21.8 | 1 |
| Histone-lysine N-methyltransferase EZH2 CHEMBL2189110 | Kd | 7.22 | 7.22 | 60.7 | 1 |
| Histone-lysine N-methyltransferase EZH1 CHEMBL2189116 | IC50 | 7.12 | 7.12 | 75.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.92 | 6.92 | 121.0 | 1 |
| Medulloblastoma cell CHEMBL4296520 | IC50 | 5.33 | 5.33 | 4640.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.2 | 4.99 | 6320.0 | 3 |
| MV4-11 CHEMBL613835 | IC50 | 5.13 | 5.13 | 7340.0 | 1 |
| BT-549 CHEMBL614072 | IC50 | 5.08 | 4.805 | 8280.0 | 4 |
| PC-3 CHEMBL390 | IC50 | 5.0 | 5.0 | 10040.0 | 1 |
| SK-OV-3 CHEMBL614925 | IC50 | 4.98 | 4.575 | 10490.0 | 2 |
| 4T1 CHEMBL612589 | IC50 | 4.98 | 4.98 | 10400.0 | 1 |
| MDA-MB-468 CHEMBL614335 | IC50 | 4.92 | 4.92 | 11920.0 | 1 |
| A2780 CHEMBL614004 | IC50 | 4.92 | 4.92 | 12000.0 | 1 |
| PA-1 CHEMBL614949 | IC50 | 4.91 | 4.91 | 12200.0 | 1 |
| HL-60 CHEMBL383 | IC50 | 4.85 | 4.85 | 14050.0 | 1 |
| SK-BR-3 CHEMBL613834 | IC50 | 4.81 | 4.81 | 15500.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.73 | 4.7 | 18800.0 | 2 |
| OVCAR-3 CHEMBL614213 | IC50 | 4.53 | 4.53 | 29800.0 | 1 |
| ES-2 CHEMBL5058622 | IC50 | 4.49 | 4.49 | 32200.0 | 1 |
| OAW-42 CHEMBL1075554 | IC50 | 4.26 | 4.26 | 55400.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Ka | 1.911 | 10^6/Ms | Homo sapiens |
| Ka | 5.83 | 10^5/M/s | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine